BSE Live
Jul 31, 16:01Prev. Close
5.10
Open Price
5.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jul 31, 15:40Prev. Close
4.95
Open Price
5.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Vivimed Labs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 16.58 | 16.58 | 16.58 | 16.58 | 16.58 | |
| Total Share Capital | 16.58 | 16.58 | 16.58 | 16.58 | 16.58 | |
| Reserves and Surplus | 3.91 | 34.83 | 78.73 | 402.69 | 469.89 | |
| Total Reserves and Surplus | 41.91 | 72.83 | 116.73 | 440.69 | 507.89 | |
| Total Shareholders Funds | 58.49 | 89.41 | 133.32 | 457.27 | 524.47 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 63.32 | 63.32 | 61.98 | 60.61 | 57.10 | |
| Deferred Tax Liabilities [Net] | 9.03 | 9.03 | 9.03 | 11.15 | 8.33 | |
| Other Long Term Liabilities | 110.56 | 124.47 | 168.14 | 168.89 | 168.53 | |
| Long Term Provisions | 4.35 | 4.07 | 3.95 | 8.04 | 6.40 | |
| Total Non-Current Liabilities | 187.26 | 200.89 | 243.11 | 248.69 | 240.37 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 311.51 | 312.16 | 314.66 | 296.33 | 193.70 | |
| Trade Payables | 33.65 | 38.84 | 70.57 | 37.41 | 32.89 | |
| Other Current Liabilities | 46.64 | 38.97 | 29.53 | 31.66 | 102.55 | |
| Short Term Provisions | 1.42 | 1.21 | 1.07 | 0.43 | 0.86 | |
| Total Current Liabilities | 393.21 | 391.17 | 415.83 | 365.82 | 330.00 | |
| Total Capital And Liabilities | 638.95 | 681.47 | 792.25 | 1,071.79 | 1,094.83 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 247.87 | 257.61 | 272.23 | 355.93 | 341.37 | |
| Intangible Assets | 67.41 | 68.71 | 70.63 | 72.88 | 75.13 | |
| Capital Work-In-Progress | 17.11 | 20.65 | 20.67 | 40.03 | 58.45 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 332.39 | 346.97 | 363.53 | 468.84 | 474.95 | |
| Non-Current Investments | 58.78 | 58.78 | 161.14 | 161.14 | 161.14 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 391.18 | 405.75 | 524.66 | 629.97 | 636.09 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 56.50 | 62.77 | 78.31 | 239.07 | 253.68 | |
| Trade Receivables | 45.80 | 59.54 | 52.96 | 63.39 | 76.70 | |
| Cash And Cash Equivalents | 0.29 | 1.14 | 3.35 | 6.78 | 6.02 | |
| Short Term Loans And Advances | 5.42 | 1.90 | 3.04 | 4.23 | 58.53 | |
| OtherCurrentAssets | 139.76 | 150.37 | 129.94 | 128.35 | 63.82 | |
| Total Current Assets | 247.78 | 275.72 | 267.59 | 441.82 | 458.75 | |
| Total Assets | 638.95 | 681.47 | 792.25 | 1,071.79 | 1,094.83 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 182.79 | 115.69 | 123.42 | 215.57 | 220.66 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.68 | 0.00 | 0.04 | 31.22 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 0.38 | 14.30 | 1.66 | 0.02 | 35.65 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 58.78 | 58.78 | 161.14 | 161.14 | 161.14 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y
04.03.2025
Vivimed Labs Consolidated December 2024 Net Sales at Rs 36.51 crore, down 11.94% Y-o-Y
16.02.2024
Vivimed Labs Standalone December 2023 Net Sales at Rs 37.14 crore, down 26.55% Y-o-Y
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y
04.03.2025
Vivimed Labs Consolidated December 2024 Net Sales at Rs 36.51 crore, down 11.94% Y-o-Y
16.02.2024
Vivimed Labs Standalone December 2023 Net Sales at Rs 37.14 crore, down 26.55% Y-o-Y